Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA)

Historical Holders from Q1 2021 to Q1 2025

Symbol
IKNA on Nasdaq
CUSIP
45175G108
Type / Class
Equity / Common Stock, $0.001 par value
Shares outstanding
48.3M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
31.7M
Holdings value
$52M
% of all portfolios
0.001%
Grand Portfolio weight change
+0%
Number of holders
53
Number of buys
12
Number of sells
-31
Average Value change %
+0%
Average buys %
+0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BIOTECHNOLOGY VALUE FUND L P 8.3% $3.39M 4.01M BVF PARTNERS L P/IL Dec 31, 2024
BML Investment Partners, L.P. 7.6% 0% $5.88M 3.65M 0% Leonard Braden Michael Dec 31, 2024
Deep Track Capital, LP 5.21% $4.13M 2.52M Deep Track Capital, LP Feb 7, 2025
GILEAD SCIENCES, INC. 3.6% $2.49M 1.52M GILEAD SCIENCES INC Dec 31, 2024

Institutional Holders of Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 108 $135 -$120K $1.25 1
2024 Q4 31.7M $52M +$1.14M $1.64 53
2024 Q3 28.4M $49.1M -$990K $1.73 57
2024 Q2 29M $47.9M -$1.77M $1.65 69
2024 Q1 30.1M $42.7M -$4.43M $1.42 56
2023 Q4 32.1M $63.3M -$2.88M $1.97 54
2023 Q3 32.7M $142M +$6.44M $4.33 58
2023 Q2 31.2M $205M +$41.7M $6.56 52
2023 Q1 25M $86.2M -$4.25M $3.45 38
2022 Q4 26.3M $69.9M -$1.37M $2.66 34
2022 Q3 26.2M $93.1M -$2.49M $3.55 37
2022 Q2 26.7M $118M -$3.05M $4.43 39
2022 Q1 27.4M $167M -$5.44M $6.10 45
2021 Q4 27.3M $342M +$20.4M $12.54 45
2021 Q3 20.9M $272M -$3.15M $12.62 39
2021 Q2 21.1M $293M +$21.2M $14.04 41
2021 Q1 19.3M $539M +$539M $28.25 27